Steen Solution
Total Payments
$367,201
Transactions
153
Doctors
78
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $367,201 | 153 | 78 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $203,076 | 23 | 55.3% |
| Unspecified | $158,266 | 39 | 43.1% |
| Food and Beverage | $5,859 | 91 | 1.6% |
Payments by Type
General
$208,935
114 transactions
Research
$158,266
39 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility | United Therapeutics Corporation | $158,266 | 6 |
Ad
Manufacturing Companies
- United Therapeutics Corporation $367,201
Product Information
- Type Device
- Total Payments $367,201
- Total Doctors 78
- Transactions 153
About Steen Solution
Steen Solution is a device associated with $367,201 in payments to 78 healthcare providers, recorded across 153 transactions in the CMS Open Payments database. The primary manufacturer is United Therapeutics Corporation.
Payment data is available from 2024 to 2024. In 2024, $367,201 was paid across 153 transactions to 78 doctors.
The most common payment nature for Steen Solution is "Consulting Fee" ($203,076, 55.3% of total).
Steen Solution is associated with 1 research study, including "Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility" ($158,266).